Directorio

392 clinical trials found.
COVID-19

We are doing this study to find out if an investigational drug called abatacept (the study drug) is an effective option when it is given along with the current standard treatment for COVID-19.

Compensation: Yes
Ages: 18-100
Non-Oncology
Duke University Hospital, Duke Regional Hospital, Duke Raleigh Hospital, Pickett Road Research
Brain and Spine Metastasis

We are doing this study to see if the study drug, QTX3034, either with or without cetuximab, is safe and effective for treating KRAS G12D mutated cancer. We are also trying to find the best dose of QTX3034 to use.

Compensation: No
Oncology
Brain and Spine Metastasis

We are doing this study to find out if an investigational drug called RMC-9805 (the study drug) is a safe and effective option for treating KRAS G12D mutated cancer. We are also trying to figure out what dose of the study drug works best for most people.

Compensation: No
Oncology
Brain and Spine Metastasis

We are doing this study to find out if an experimental drug called RO7589831 (the study drug) is a safe and effective option for cancers with solid tumors. We also want to find out what the best dose of the study drug is in this study.

Compensation: No
Oncology
Pediatric Cancer

If you choose to join this study, you will:<ul>
<li>Get 2-6 cycles of Inotuzumab Ozagamicin, lasting 1 month per cycle</li>
<li>Get Methotrexate on day one during cycle 1 and on day 28 of cycles 2, 4 and 6</li>
<li>Get about 3-5 mL of blood collected prior to treatment and at three time points during cycle 1 and 4 time points during cycle 2</li></ul>

Compensation: No
Oncology
Hematologic Malignancies and Cellular Therapy

We are doing this study to figure out how well an investigational drug called CGT9486 (the study drug - also known as bezuclastinib) works in people who are diagnosed with a type of Nonadvanced Systemic Mastocytosis (NonAdvSM). These types are either Indolent Systemic Mastocytosis (ISM) or Smoldering Systemic Mastocytosis (SSM).

Compensation: No
Oncology

We are doing this study to evaluate whether exercise training following allogeneic stem cell transplant can improve physical function, cognitive function, mental health, social support, and quality of life.

Compensation: No
Skin Cancer - Melanoma

We are doing this study to find out how much skin should be removed from around a melanoma to lower the chances of the melanoma coming back. We don't have enough evidence to know exactly how much skin to remove around the melanoma to give people the best chance at a good outcome.

Compensation: No
Oncology